Earnings, virus news to dictate direction of stock prices
US stocks rose slightly last week as a vaccine breakthrough boosted hopes that the world could return to normal.
The gains could moderate this week if earnings reports are as dire as anticipated and Covid-19 outbreaks in the US sun belt become deadlier.
Shares of Moderna surged after the biotech company, which has never succeeded in bringing a drug to market, said that its experimental, RNA-based vaccine showed impressive levels of efficacy in a mid-stage clinical trial.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
S&P slashes Boeing credit outlook as rating hovers above junk status
Honda to spend US$11 billion on EV strategy in Canada
GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology
Mapletree Industrial Trust Q4 DPU rises 0.9% to S$0.0336
Nasdaq’s profit falls as shaky economy keeps IPO revival elusive
iFast Q1 net profit surges on ePension unit performance